ResearchMoz

Dyslexia Global Clinical Trials Review, H1, 2013

GlobalData
Published Date » 2013-04-12
No. Of Pages » 59
Dyslexia Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, Dyslexia Global Clinical Trials Review, H1, 2013" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. 

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Dyslexia 5
Symptoms of dyslexia are: 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by BRIC Nations 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by E7 Nations 16
Clinical Trials in E7 Nations by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Dyslexia 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Eli Lilly and Company 26
Clinical Trial Overview of Eli Lilly and Company 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
University Hospital, Tours 27
Clinical Trial Overview of University Hospital, Tours 27
Macquarie University 28
Clinical Trial Overview of Macquarie University 28
University of Tasmania 29
Clinical Trial Overview of University of Tasmania 29
University of Munster 30
Clinical Trial Overview of University of Munster 30
McGill University 31
Clinical Trial Overview of McGill University 31
University of Oxford 32
Clinical Trial Overview of University of Oxford 32
Vanderbilt University 33
Clinical Trial Overview of Vanderbilt University 33
Rabin Medical Center 34
Clinical Trial Overview of Rabin Medical Center 34
Five Key Clinical Profiles 35

Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries, 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Dyslexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 12
Dyslexia Therapeutics Clinical Trials, BRIC Countries, 2013* 13
Dyslexia Therapeutics Clinical Trials, G7 Countries, 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Clinical Trials, E7 Countries, 2013* 16
Dyslexia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 21
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 24
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 26
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2013* 27
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2013* 28
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2013* 29
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2013* 30
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2013* 31
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 32
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 33
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2013* 34

List of Figures


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries (%), 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11
Dyslexia Therapeutics Clinical Trials, G7 Countries (%), 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
GlobalData Methodology 58

Upcoming Reports:

Feldspar And Nepheline Syenite Market - Global Forecast, Market Share, Size, Growth And Industry Analysis 2011 - 2017
By - Transparency Market Research
Nepheline Syenite is a type of igneous rock which is formed out of molten magma in the absence of silica. It is similar to granite and constitutes three types of minerals which are the microcline form of feldspar, the albite form of feldspar and nepheline. Their percentage varies - microline constitutes 24.2%, nepheline 21.8% and albite 54% respectively. Owing to the increase in demand from major markets such as filters, glass, adhesives and ceramics, the feldspar and nepheline syenite market is estimated to reach 14.1 million tons in 2017. The feldspar market leaders in 2011...
Unconventional Natural Gas Extraction Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Natural gas obtained from coal, gas shale, and gas hydrates are generally referred to as unconventional natural gases. There has been a rapid growth in the exploration and production of unconventional natural gas due to the need for power generation. Technological improvements in the extraction methods like drilling and hydraulic fracturing and benefits of natural gas over other fuels for power generation are some important reasons driving this market.  Widespread availability of unconventional natural gas resources is also adding to their increasing use in the...
Diagnostic Ophthalmic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Diagnostic ophthalmic devices are technology based devices used for diagnosis of any defect in the human visual pathway. The causeof the defect may be any eye related disorder, an infection or can be congenital. Many newly developed and easy-to-use ophthalmic diagnostics are helping the patients worldwide. The diagnostic ophthalmic devices market is expected to witness remarkable growth in the near future owing to increased prevalence of eye related disorders such aspresbyopia, diabetic retinopathy, macular degeneration, cataracts, uveitis and keratoconusacross the globe.  The...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...